{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Novel Targets to Treat Depression: Opioid-Based Therapeutics ((Non-Physician Credit))
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
The certificate for this activity is for NON-PHYSICIANS.Method of Participation in the Learning Process/Evaluation Method Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form. Getting the Most out of the Activity As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed. While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.Learning Objectives
After completing this continuing education activity you will be able to:
- Identify the effects of dysregulated opioid signalling in depression
- Evaluate the use of opioid compounds and ketamine in patients with depression
Disclosures
The authors, faculty and staff in a position to control the content of this CME activity, and their spouses/life partners (if any), have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations relevant to this CME activity.
Disclaimer Clinicians should ensure that all diagnostic and therapeutic modalities are prescribed and used appropriately, based on accepted standards of care. Use of any drugs, devices, and imaging techniques should be guided by approved labeling/full prescribing information, best available evidence, and professional judgment. Faculty have been instructed that their content should be fair balanced and based on best available evidence. The information presented in this activity is the responsibility of the faculty and does not reflect the opinions of the provider.
Price:
$12.95
Credits:
- ACCME 1.0 CME
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Other Health Professional
Test Code: HRPN0120
Published: Jan/Feb 2020
Expires: 1/1/2026
Sources:
Harvard Review of Psychiatry
Required Passing Score: 7/10 (70%)
Categories:
Addiction
,
Psychiatric
Specialties:
Addiction Medicine,
Psychiatry
Topics:
Depression
,
Opioid Analgesics